Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas

This publication has 16 references indexed in Scilit:

• Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas
  Laboratory Investigation, 2004
• A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)
  British Journal of Cancer, 2003
• CpG island methylation in carcinoid and pancreatic endocrine tumors
  Oncogene, 2003
• Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy
  The Oncologist, 2002
• Immunohistochemical expression of transforming growth factor α and epidermal growth factor receptor in pancreatic endocrine tumors
  Human Pathology, 2001
• Prognostic Significance of p27, Ki-67, and Topoisomerase IIα Expression in Clinically Nonfunctioning Pancreatic Endocrine Tumors
  Endocrine Pathology, 2000
• A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
  Journal of Clinical Investigation, 1997
• Immunohistochemical Expression of Transforming Growth Factor Alpha and Epidermal Growth Factor Receptor in Gastrointestinal Carcinoids
  The American Journal of Surgical Pathology, 1997
• Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours
  International Journal of Cancer, 1995
• Expression of Growth Factors and Their Receptors in Neuroendocrine Gut and Pancreatic Tumors, and Prognostic Factors for Survival
  Annals of the New York Academy of Sciences, 1994